Publication | Closed Access
Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn’s Disease
131
Citations
18
References
2014
Year
InflammationChronic Inflammatory DiseasesCo-treatment DoesAnti-inflammatoryReduce Trough LevelCrohn ’ImmunologyGastroenterologyImmune-mediated Inflammatory DiseasesMedicineInflammatory Disease
| Year | Citations | |
|---|---|---|
Page 1
Page 1